Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
A Prospective, Multicenter, Randomized Controlled Phase II Study to Evaluate the Efficacy and Safety of Adebrelimab Combined with Chemotherapy with or without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer
Epistemonikos ID: 9149ac002a9d9fe2176cc6e4aad0631cc0106e9a
First added on: Apr 04, 2025